Prognostic significance of surrogate measures for forced vital capacity in an elderly population

Journal of the American Medical Directors Association

Volumn 11, Issue 8, 2010, Pages 598-604

  Pedone, Claudio ^a   Bellia, Vincenzo ^b   Sorino, Claudio ^b   Forastiere, Francesco ^c   Pistelli, Ricardo ^d   Antonelli Incalzi, Raffaelle ^a,e  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c ASL Roma E   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e Fondazione San Raffaele   (Italy)

Author keywords

Aged 65 and older; Prognosis; Spirometry; Surrogate markers

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ELDERLY CARE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR;

EID: 77957245146     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2009.12.003     Document Type: Article

References (25)

1. Jegal Y., Kim D.S., Shim T.S., et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005, 171:639-644.
2. Mannino D.M., Doherty D.E. Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: Findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006, 100:115-122.
3. Scarlata S., Pedone C., Fimognari F.L., et al. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly. Respir Med 2008, 102:1349-1354.
4. Lange P., Nyboe J.R., Appleyard M., et al. Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990, 43:867-873.
5. Dunhill M.S. The anatomy of restrictive lung disease. Hum Pathol 1970, 1. 265-174.
6. Fimognari F.L., Pasqualetti P., Moro L., et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 2007, 62:760-765.
7. Antonelli Incalzi R., Pedone C., Cesari M., et al. Relationship between the occiput-wall distance and physical performance in the elderly: A cross sectional study. Aging Clin Exp Res 2007, 19:207-212.
8. Leech J.A., Dulberg C., Kellie S., et al. Relationship of lung function to severity of osteoporosis in women. Am Rev Respir Dis 1990, 141:68-71.
9. Lange P., Nyboe J., Jensen G., et al. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J 1991, 4:1080-1087.
10. Bellia V., Pistelli R., Catalano F., et al. Quality control of spirometry in the elderly. The SA.R.A. Study. Am J Respir Crit Care Med 2000, 161:1094-1100.
11. Vandevoorde J., Verbanck S., Schuermans D., et al. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 2005, 127:1560-1564.
12. Swanney M.P., Jensen R.L., Crichton D.A., et al. FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000, 162:917-919.
13. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
14. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
15. Garcia-Rio F., Pino J.M., Dorgham A., et al. Spirometric reference equations for European females and males aged 65-85 yrs. Eur Respir J 2004, 24:397-405.
16. Mannino D.M., Buist A.S., Petty T.L., et al. Lung function and mortality in the United States: Data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-393.
17. Eaton T., Withy S., Garrett J.E., et al. Spirometry in primary care practice: The importance of quality assurance and the impact of spirometry workshops. Chest 1999, 116:416-423.
18. Bellia V., Sorino C., Catalano F., et al. Validation of FEV6 in the elderly: Correlates of performance and repeatability. Thorax 2008, 63:60-66.
19. Swanney M.P., Beckert L.E., Frampton C.M., et al. Validity of the American Thoracic Society and other spirometric algorithms using FVC and Forced Expiratory Volume at 6 s for predicting a reduced total lung capacity. Chest 2004, 126:1861-1866.
20. Vandevoorde J., Verbanck S., Schuermans D., et al. Obstructive and restrictive spirometric patterns: Fixed cut-offs for FEV1/FEV6 and FEV6. Eur Respir J 2006, 27:378-383.
21. Carey E.C., Covinsky K.E., Lui L.Y., et al. Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 2008, 56:68-75.
22. van Dijk P.T.M., Mehr D.R., Ooms M.E., et al. Comorbidity and 1-year mortality risks in nursing home residents. J Am Geriatr Soc 2005, 53:660-665.
23. McEvoy C.E., Ensrud K.E., Bender E., et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:704-709.
24. Cauley J.A., Thompson D.E., Ensrud K.C., et al. Risk of mortality following clinical fractures. Osteoporos Int 2000, 11:556-561.
25. Mahler D.A., Criner G.J. Assessment tools for chronic obstructive pulmonary disease: Do newer metrics allow for disease modification?. Proc Am Thorac Soc 2007, 4:507-511.